Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-MH-25-181

Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)

Closed on November 8, 2024.

Posted
June 14, 2024
Close date
November 8, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $194,375 in first-year total cost, median $194,375.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-L (02)]1

Most frequent institutions

  1. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under RFA-MH-25-181 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Brain structure and function and the CNS HIV reservoir in older people living with HIV1R21NS148275-01DAYAN, ERANDIAZ, MONICA MARIAUNIV OF NORTH CAROLINA CHAPEL HILL, NC$194,375ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-MH-25-181: Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience